AUA 2017: Absence of learning curve impact may let MRI-TRUS fusion guided biopsy up for early diagnosis of prostate cancer
With the introduction of new technology there is always a fear for early adopters there will be a steep learning curve. In accordance this study importantly evaluated if there is a learning curve for the detection of the clinically significant prostate cancer with MRI-TRUS fusion biopsies. With the study findings of no significant learning curve, the technology should be able to be more rapidly utilized. Patients should benefit from increased introduction in MRI-fusion biopsies offered.
Presented by Giuliana Lista , from Humantias University, Milano, Italy
Written By: Janet Baack Kukreja (@janetkukreja), MD, MPH, Urologic Oncology Fellow, Department of Urology, UT MD Anderson Cancer Center, Houston, TX, Ashish M. Kamat, MD, MBBS, FACS, Wayne B. Duddlesten Professor, Department of Urology, UT MD Anderson Cancer Center, Houston TX
at the 2017 AUA Annual Meeting - May 12 - 16, 2017 – Boston, Massachusetts, USA